Diabetes and vascular complications: normoxia versus hypoxia

*Diabetes and vascular complications: normoxia versus hypoxia* - DM-Hypoxia

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35263

Enrollment

Registered

2012-04-10

Start date

2012-05-21

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus type 2

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Diagnosed with type 2 diabetes mellitus at least 2 years ago

Exclusion criteria

Exclusion criteria: - Cardiovascular disease - Hypercholesterolemia and/or subjects on cholesterol-lowering drugs - Hypertension (>160 mmHg systolic and/or >90 mmHg diastolic pressure) and/or subjects on antihypertensive drugs - Smoking - Type I diabetes mellitus - Older than 65 years - Subjects with vascular complications due to type 2 diabetes mellitus (e.g. diabetic foot ulcer)

Design outcomes

Primary

Measure	Time frame
1) Endothelial function (measured as the flow-mediated dilation (FMD)) 2) Vascular structure (measured as the intima-media thickness (IMT)) 3) Metabolic function (measured as insulin resistance)	—

Countries

Netherlands

Outcome results